AVE 25.0% 0.3¢ avecho biotechnology limited

targeting statins, page-24

  1. 34,916 Posts.
    lightbulb Created with Sketch. 480
    I hope I don't turn out to be as wrong as I was in placing so much faith in the management of Andrew King in Oxiana, a trust that cost me a six figure amount.

    Interesting. Oxiana made me a six figure amount. Investment, as always, is all in the timing.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.